PINALAWAK ng Bureau of Internal Revenue (BIR) ang listahan ng mga gamot na exempted sa value added tax (VAT).
Ito ang inilabas ng BIR sa ilalim ng Revenue Memorandum Circular No. 17-2024.
Kabilang sa mga idinagdag para sa vat exemption ay ang mga gamot para sa Cancer; panitumumab (100mg/5ml) (concentrate solution for infusion), fulvestrant (50mg/ml) (concentrate solution for infusion).
Diabetes; teneligliptin (as hydrobromide hydrate) (20 mg), sitagliptin (as phospate monohydrate) + metformin hci (50mg/500mg), sitagliptin (50 mg), sitagliptin (10 mg), metformin hydrochloride (500 mg).
High cholesterol; atorvastatin calcium (20 mg), atorvastatin + fenofibrate (40 mg/160 mg).
Mental illness; desvenlafaxine (as succinate monohydrate) (50 mg).
Tuberculosis; bedaquiline (as fumarate) (100 mg); isoniazid + pyridoxine hci (200mg/10 mg per 5 ml).
Hypertension; clonidine hydrochloride (150 mcg/ml, solution for injection [im/iv]), clonidine hydrochloride (150 mcg, tablet), lisinopril (as dihydrate) (5mg, tablet), lisinopril (as dihydrate) (10 mg, tablet), lisinopril (as dihydrate) (20 mg, tablet).
Kidney diseases; mannitol (20g/100ml, solution for injection [iv]), tolvaptan (15 mg, tablet), tolvaptan (30 mg, tablet), alpha ketoanalogues + essential amino acids (film-coated tablet) cancer, panitumumab (100mg/5ml) (concentrate solution for infusion), fulvestrant (50mg/ml) (concentrate solution for infusion).
